We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.37%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.4B
AUM Growth
-$234M
(-0.62%)
Cap. Flow
-$832M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.05%
Holding
2,051
New
47
Increased
483
Reduced
1,317
Closed
203
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$240M |
| 2 |
Sysco
SYY
|
+$180M |
| 3 |
Synopsys
SNPS
|
+$83.9M |
| 4 |
C.H. Robinson
CHRW
|
+$42.1M |
| 5 |
United Bankshares
UBSI
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$216M |
| 2 |
Apple
AAPL
|
+$189M |
| 3 |
Microsoft
MSFT
|
+$115M |
| 4 |
Meta Platforms (Facebook)
META
|
+$68.7M |
| 5 |
Broadcom
AVGO
|
+$65.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.13% |
| 2 | Consumer Staples | 11.3% |
| 3 | Industrials | 10.65% |
| 4 | Financials | 9.24% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
OmniAb
OABI
$294M
| $74.1K | ﹤0.01% |
19,749
-5,149
| -21% | -$23.5K |
|
1702
Unisys
UIS
$227M
| $73.6K | ﹤0.01% |
17,812
+5,866
| +49% | +$28.7K |
|
1703
SoundHound AI
SOUN
$2.68B
| $73K | ﹤0.01% |
18,491
-6,312
| -25% | -$29.3K |
|
1704
Archer Aviation
ACHR
$3.64B
| $71.9K | ﹤0.01% |
20,439
-6,977
| -25% | -$25.9K |
|
1705
MaxCyte
MXCT
$116M
| $71.2K | ﹤0.01% |
18,153
-4,809
| -21% | -$20.7K |
|
1706
Alector
ALEC
$164M
| $71K | ﹤0.01% |
15,639
-4,070
| -21% | -$20.9K |
|
1707
Clear Channel Outdoor Holdings
CCO
$1.23B
| $70.9K | ﹤0.01% |
50,251
-17,153
| -25% | -$25.3K |
|
|
SLRN
1708
DELISTED
ACELYRIN
SLRN
| $69.9K | ﹤0.01% |
15,841
-4,030
| -20% | -$18.9K |
|
1709
Lifestance Health
LFST
$4.16B
| $69.8K | ﹤0.01% |
14,216
-4,853
| -25% | -$29.3K |
|
1710
Applied Digital
APLD
$7.77B
| $69.6K | ﹤0.01% |
11,696
-3,992
| -25% | -$15.5K |
|
1711
Pacific Biosciences
PACB
$422M
| $69.3K | ﹤0.01% |
50,577
-13,493
| -21% | -$27.2K |
|
|
VERV
1712
DELISTED
Verve Therapeutics
VERV
| $68.4K | ﹤0.01% |
14,007
-3,689
| -21% | -$23.2K |
|
|
STKL
1713
DELISTED
SunOpta
STKL
| $67.8K | ﹤0.01% |
12,556
-4,286
| -25% | -$25.2K |
|
1714
Opko Health
OPK
$921M
| $67.5K | ﹤0.01% |
54,027
-18,443
| -25% | -$23.9K |
|
1715
ARKO Corp
ARKO
$890M
| $67.2K | ﹤0.01% |
10,719
-3,660
| -25% | -$19.7K |
|
1716
Prime Medicine
PRME
$533M
| $65.3K | ﹤0.01% |
12,707
-2,569
| -17% | -$15.6K |
|
|
BRY
1717
DELISTED
Berry Corp
BRY
| $65.2K | ﹤0.01% |
10,099
-3,447
| -25% | -$25.7K |
|
1718
Erasca
ERAS
$6.63B
| $63.4K | ﹤0.01% |
26,849
+1,762
| +7% | +$3.8K |
|
1719
Vanda Pharmaceuticals
VNDA
$312M
| $63K | ﹤0.01% |
11,158
-3,022
| -21% | -$15.6K |
|
1720
Anavex Life Sciences
AVXL
$222M
| $62.9K | ﹤0.01% |
14,905
-3,837
| -20% | -$15.5K |
|
|
OLO
1721
DELISTED
Olo Inc
OLO
| $61.3K | ﹤0.01% |
13,858
-4,732
| -25% | -$22.4K |
|
1722
Xeris Biopharma Holdings
XERS
$1.44B
| $60.7K | ﹤0.01% |
26,974
-6,614
| -20% | -$13.3K |
|
1723
Clean Energy Fuels
CLNE
$447M
| $60.7K | ﹤0.01% |
22,729
-7,760
| -25% | -$20K |
|
1724
SmartRent
SMRT
$183M
| $60.1K | ﹤0.01% |
25,160
-8,589
| -25% | -$21.1K |
|
1725
Navitas Semiconductor
NVTS
$2.66B
| $59.6K | ﹤0.01% |
15,169
-5,179
| -25% | -$21.8K |
|
Similar funds
ProShare Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, ProShare Advisors held 2,051 positions worth $37.4B, down 0.62% from $37.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
ProShare Advisors's Q2 2024 filing shows 47 new, 483 increased, 1,317 reduced and 203 closed positions. Its largest new stake was KKR & Co: 135,149 shares worth $14.2M. The largest sale was 3M, an estimated $216M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q2 2024 buy was KKR & Co: 135,149 shares worth $14.2M.
- ProShare Advisors added most to Qualcomm in Q2 2024, an estimated $240M increase.
- ProShare Advisors's biggest Q2 2024 reduction was 3M, cutting an estimated $216M.
- ProShare Advisors fully exited Leggett & Platt in Q2 2024, selling an estimated $24.6M.
- ProShare Advisors's ten largest holdings make up 26% of its $37.4B portfolio in Q2 2024.
- ProShare Advisors opened 47 new positions and closed 203 in Q2 2024.
- ProShare Advisors's portfolio value fell 0.62% quarter-over-quarter to $37.4B.
Based on ProShare Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.